Aberrant DNA methylation of E-Cadherin and p16 genes in rat lung adenocarcinomas induced by N-nitrosobis(2-hydroxypropyl)amine

Molecular Carcinogenesis

Volumn 45, Issue 2, 2006, Pages 106-111

  Kato, Ayumi ^a   Shimizu, Kyoko ^a   Shimoichi, Yozo ^a   Fujii, Hiromasa ^b   Honoki, Kanya ^b   Tsujiuchi, Toshifumi ^a  

^a KINKI UNIVERSITY   (Japan)

^b NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

DNA methylation; E cadherin; Nitrosamine; p16; Rat

Indexed keywords

BIS(2 HYDROXYPROPYL)NITROSAMINE; BISULFITE; PROTEIN P16; RNA; UVOMORULIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER MODEL; CONTROLLED STUDY; DNA METHYLATION; E CADHERIN GENE; GENE; GENE EXPRESSION; GENE SEQUENCE; LUNG ADENOCARCINOMA; LUNG CARCINOGENESIS; LUNG PARENCHYMA; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RAT STRAIN; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; SEQUENCE ANALYSIS; TUMOR SUPPRESSOR GENE;

ADENOCARCINOMA; ANIMALS; CADHERINS; DNA METHYLATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, P16; LUNG; LUNG NEOPLASMS; MALE; NITROSAMINES; RATS; RATS, WISTAR; REFERENCE VALUES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

ANIMALIA; RATTUS NORVEGICUS;

EID: 32044438696     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.20162     Document Type: Article

References (33)

1. Konishi Y, Denda A, Kondo H, Takahashi S. Lung carcinomas induced by oral administration of N-bis(2-hydroxypropyl)nitrosamine in rats, Jpn J Cancer Res 1976;67:773-780.
2. Konishi Y, Kondoh H, Denda A, Takahashi S, Inui S. Lung carcinomas induced by oral administration of N-bis(2-hydroxypropyl)nitrosamine in rats. In: Severi I, editor. Tumors of early life in man and animals. Perugia Quadrennaial International Conference of Cancer. Perugia: Division of Cancer Research, Perugia University; 1978. pp 637-649.
3. Kitada H, Tsutsumi M, Tsujiuchi T, et al. Frequent mutations of Ki-ras but no mutations of Ha-ras and p53 in lung lesions induced N-nitrosobis(2- hydroxypropyl) amine by in rat. Mol Carcinog 1996;115:276-283.
4. Tsujiuchi T, Sasaki Y, Tsutsumi M, Konishi Y. Alterations of the M6p/lgf2 receptor gene in lung adenocarcinomas induced by N-nitrosobis(2-hydroxypropyl) amine in rat. Mol Carcinog 2003;36:32-37.
5. Tsujiuchi T, Sasaki Y, Tsutsumi M, Konishi Y. Mutations and reduced expression of the transforming growth factor-βreceptor II gene in rat lung adenocarcinomas induced N-nitrosobis(2-hydroxypropyl) amine. Jpn J Cancer Res 2000; 91:1090-1095.
6. Tsujiuchi T, Sasaki Y, Tsutsumi M, Konishi Y. Mutations of the smad2 and smad4 genes in lung adenocarcinomas induced N-nitrosobis(2-hydroxypropyl) amine in rats. Mol Carcinog 2000;29:87-91.
7. Tsujiuchi T, Sasaki Y, Murata N, et al. FHIT alterations in lung adencarcinomas induced by N-nitrosobis(2-hydroxypropyl)amine in rats. Carcinogenesis 2001;22:2017-2022.
8. Tsujiuchi T, Sasaki Y, Oka Y, et al. Alterations of the Dutt1/Robo1 gene in lung adenocarcinomas induced by N-nitrosobis(2-hydroxypropyl)amine in rats. Mol Carcinog 2004;40:241-246.
9. Shimizu K, Kato A, Hinotsume D, et al. Reduced expressions of Foxp1 and Rassf1 a gene in lung adenocarcinomas induced N-nitrosobis(2-hydroxypropyl) amine in rats. Cancer Lett in press 2005.
10. Zingg J-M, Jones PA. Genetic and epigenetic aspects of DNA methylation on genome expression, evolution, mutation and carcinogenesis. Carcinogenesis 1997;18: 869-882.
11. Jones PA, Laird PW. Cancer epigenetics comes of age. Nat Genet 1999;21:163-167.
12. Clark SJ, Harrison J, Molloy PL. Sp1 binding is inhibited by (m)Cp(m)CpG methylation. Gene 1997;195:67-71.
13. Prendergast GC, Ziff EB. Methylation-sensitive sequence-specific DNA binding by the c-Myc basic region. Science 1991;251:186-189.
14. Baylin SB, Herman JG. DNA alterations in cancer: Genetic and epigenetic alterations. In: Ehrlich M, editor. DNA alterations in cancer. Natick: Eaton Publishing: 2000. pp 293-309.
15. Issa JP. DNA alterations in cancer: Genetic and epigenetic alterations. In: Ehrlich M, editor. DNA alterations in cancer. Natick: Eaton Publishing: 2000. pp 311-322.
16. Blanco D, Vicent S, Elizegi E, et al. Altered expression of adhesion molecules and epithelial-mesenchymal transition in silica-induced rat lung carcinogenesis. Lab Invest 2004;84:999-1012.
17. INK4a in primary rat lung tumors. Mol Cell Biol 1997;17:1366-1374.
18. Abe M, Okochi E, Kuramoto T, et al. Cloning of 5′upstream region of the rat p16 gene and its role in silencing. Jpn J Cancer Res 2002;93:1100-1106.
19. INK4agene and methylation pattern of CpG sites in the promoter region in rat tumor cell lines. Mol Carcinog 2004;39:10-14.
20. Yoshimura K, Kanai Y, Ochiai A, Shimoyama Y, Sugimura T, Hirohashi S. Silencing of the E-cadherin invasion-suppressor gene by CpG methylation in human carcinomas. Natl Acad Sci USA 1995;92:7416-7419.
21. Kanai Y, Ushijima S, Hui AM, et al. The E-cadherin gene is silenced by CpG methylation in human hepatocellular carcinomas. Int J Cancer 1997;71:355-359.
22. Sulzer MA, Leers MP, Van NJ, Bollen EC, Theunissen PH. Reduced E-cadherin expression is associated with increased lymph node metastasis and unfavorable prognosis in nonsmall cell lung cancer. Am J Resp Crit Care 1998;157: 1319-1323.
23. Bohm M, Totzeck B, Birchmeier W, Wieland I. Differences of E-cadherin expression levels and patterns in primary and metastatic human lung cancer. Clin Exp Metastasis 1994;12: 55-62.
24. Shibanuma H, Hirano T, Tsuji K, et al. Influence of E-cadherin dysfunction upon local invasion and metastasis in non-small cell lung cancer. Lung Cancer 1998;22:85-95.
25. KaseS, Sugio K, Yamazaki K, Okamoto T, Yano T, Sugimachi K. Expression of E-cadherin and β-Catenin in human non-small cell lung cancer and the clinical significance. Clin Cancer Res 2000;6:4789-4796.
26. Liggett WH Jr, Sidransky D. Role of the p16 tumor suppressor gene in cancer. J Clin Oncol 1998;16:1197-1206.
27. Gonzalez-Zulueta M, Bender CM, Yang AS, et al. Methylation of the 5′CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing. Cancer Res 1885;55:4531-4535.
28. Merio A, Herman JG, Mao L, et al. 5′CpG island methylation is associated with transcriptional silenceing of the tumor suppressor p16/CDKN2/MTS1 in human cancers. Nat Med 1995;1:686-692.
29. INK4a is an early event in lung cancer and a potential biomarker for early diagnosis. Proc Natl Acad Sci USA 1998;95:11891-11896.
30. Jiao J, Pienkoqska M, Glickman BW, Zielenska M. Molecular analysis of mutations induced by ethylating N-nitoroso compounds in the lacl gene of Eschericia coli. Mutat Res 1996;352:39-45.
31. Rountree MR, Bachman KE, Herman JG, Baylin SB. DNA methylation, chromatin inheritance and cancer. Oncogene 2001;20:3156-3165.
32. Song JZ, Stirzaker C, Harrison J, Melki JR, Clark SJ. Hypermethylation trigger of the glutathione-S-transferase gene (GSTP1) in prostate cancer cells. Oncogene 2002; 21:1048-1061.
33. Zabarovsky ER, Lerman MI, Minna JD. Tumor suppressor genes on chromosome 3p involved in the pathogenesis of lung and other cancers. Oncogene 2002;21:6915-6935.